• Je něco špatně v tomto záznamu ?

Medicinal Use of Testosterone and Related Steroids Revisited

J. Tauchen, M. Jurášek, L. Huml, S. Rimpelová

. 2021 ; 26 (4) : . [pub] 20210215

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019245

Grantová podpora
No. CZ.02.1.01/0.0/0.0/16_019/0000845 European Regional Development Fund - Project
A1_FPBT_2020_004 The Institutional Plan of the UCT Prague

Testosterone derivatives and related compounds (such as anabolic-androgenic steroids-AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, they have important pharmacological activities that cannot be easily replaced by other drugs and have therapeutic potential in a range of conditions (e.g., wasting syndromes, severe burns, muscle and bone injuries, anemia, hereditary angioedema). Testosterone and related steroids have been in some countries treated as controlled substances, which may affect the availability of these agents for patients who need them for therapeutic reasons in a given country. Although these agents are currently regarded as rather older generation drugs and their use may lead to serious side-effects, they still have medicinal value as androgenic, anabolic, and even anti-androgenic agents. This review summarizes and revisits the medicinal use of compounds based on the structure and biological activity of testosterone, with examples of specific compounds. Additionally, some of the newer androgenic-anabolic compounds are discussed such as selective androgen receptor modulators, the efficacy/adverse-effect profiles of which have not been sufficiently established and which may pose a greater risk than conventional androgenic-anabolic agents.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019245
003      
CZ-PrNML
005      
20210830100825.0
007      
ta
008      
210728s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/molecules26041032 $2 doi
035    __
$a (PubMed)33672087
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Tauchen, Jan $u Department of Food Science, Faculty of Agrobiology, Food, and Natural Resources, Czech University of Life Sciences Prague, Kamýcká 129, 165 00 Prague-Suchdol, Czech Republic
245    10
$a Medicinal Use of Testosterone and Related Steroids Revisited / $c J. Tauchen, M. Jurášek, L. Huml, S. Rimpelová
520    9_
$a Testosterone derivatives and related compounds (such as anabolic-androgenic steroids-AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, they have important pharmacological activities that cannot be easily replaced by other drugs and have therapeutic potential in a range of conditions (e.g., wasting syndromes, severe burns, muscle and bone injuries, anemia, hereditary angioedema). Testosterone and related steroids have been in some countries treated as controlled substances, which may affect the availability of these agents for patients who need them for therapeutic reasons in a given country. Although these agents are currently regarded as rather older generation drugs and their use may lead to serious side-effects, they still have medicinal value as androgenic, anabolic, and even anti-androgenic agents. This review summarizes and revisits the medicinal use of compounds based on the structure and biological activity of testosterone, with examples of specific compounds. Additionally, some of the newer androgenic-anabolic compounds are discussed such as selective androgen receptor modulators, the efficacy/adverse-effect profiles of which have not been sufficiently established and which may pose a greater risk than conventional androgenic-anabolic agents.
650    _2
$a zvířata $7 D000818
650    _2
$a nové syntetické drogy $x chemie $x terapeutické užití $7 D015198
650    _2
$a lidé $7 D006801
650    _2
$a rostliny $x chemie $7 D010944
650    _2
$a prekurzory léčiv $x chemie $x terapeutické užití $7 D011355
650    _2
$a steroidy $x chemie $x terapeutické užití $7 D013256
650    _2
$a testosteron $x agonisté $x analogy a deriváty $x chemie $x terapeutické užití $7 D013739
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Jurášek, Michal $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, Prague 6, 166 28 Prague, Czech Republic
700    1_
$a Huml, Lukáš $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, Prague 6, 166 28 Prague, Czech Republic
700    1_
$a Rimpelová, Silvie $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, Prague 6, 166 28 Prague, Czech Republic
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 26, č. 4 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33672087 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100825 $b ABA008
999    __
$a ok $b bmc $g 1690139 $s 1139691
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 26 $c 4 $e 20210215 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
GRA    __
$a No. CZ.02.1.01/0.0/0.0/16_019/0000845 $p European Regional Development Fund - Project
GRA    __
$a A1_FPBT_2020_004 $p The Institutional Plan of the UCT Prague
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace